SCICLONE PHARMACEUTICALS INC: cashflow_investing
| Value | {"amount": -87000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2013-01-01 – 2013-06-30 |
| Status | current |
| Entity | SCICLONE PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:47:37.333294+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0e5a8c6f-9653-4ad1-88f3-59dd41dcabaf
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-13-327911Retrieved: 2026-08-19T08:47:37.333294+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000880771/cashflow-investing/2013-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0e5a8c6f-9653-4ad1-88f3-59dd41dcabaf
History
- no predecessors — first report